---
layout: post
title: "The Gross Law Firm Reminds Ultragenyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 - RARE"
date: 2026-02-19T14:00:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-ultragenyx-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026--rare-302692356.html
significance: 8.00
---

<p>NEW YORK, Feb. 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE). Shareholders who purchased shares of RARE during the class period listed are encouraged to contact the firm regarding possible lead...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-ultragenyx-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026--rare-302692356.html)

**Published:** 2026-02-19 14:00:00 +0000

**Significance Score:** 8.00

[View original](https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-ultragenyx-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-april-6-2026--rare-302692356.html)
